CEP
MRK icon

Chicago Equity Partners’s Merck MRK Stock Holding History

Chicago Equity Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$7.43M Sell
101,179
-17,282
-15% -$1.36M 0.75% 14
2019
Q4 		$10.3M Sell
118,461
-56,361
-32% -$4.63M 0.59% 15
2019
Q3 		$14M Buy
174,822
+3,893
+2% +$312K 0.67% 10
2019
Q2 		$13.7M Sell
170,929
-93,382
-35% -$7.15M 0.61% 15
2019
Q1 		$21M Sell
264,311
-18,979
-7% -$1.42M 0.81% 8
2018
Q4 		$20.7M Buy
283,290
+6,728
+2% +$475K 0.83% 9
2018
Q3 		$18.7M Sell
276,562
-24,198
-8% -$1.54M 0.55% 30
2018
Q2 		$17.4M Buy
300,760
+72,988
+32% +$4.12M 0.53% 29
2018
Q1 		$11.8M Sell
227,772
-131,273
-37% -$7.09M 0.38% 61
2017
Q4 		$19.3M Buy
359,045
+341
+0.1% +$18.9K 0.59% 25
2017
Q3 		$21.9M Sell
358,704
-147,480
-29% -$8.94M 0.69% 15
2017
Q2 		$31M Buy
506,184
+25,199
+5% +$1.53M 0.83% 14
2017
Q1 		$29.2M Sell
480,985
-62,618
-12% -$3.8M 0.84% 19
2016
Q4 		$30.5M Buy
543,603
+5,937
+1% +$347K 0.81% 23
2016
Q3 		$32M Buy
537,666
+185,145
+53% +$10.8M 0.89% 20
2016
Q2 		$19.4M Sell
352,521
-133,148
-27% -$7.09M 0.57% 50
2016
Q1 		$24.5M Buy
485,669
+28,521
+6% +$1.4M 0.72% 35
2015
Q4 		$23M Buy
457,148
+56,938
+14% +$2.87M 0.61% 46
2015
Q3 		$18.9M Sell
400,210
-50,875
-11% -$2.7M 0.53% 61
2015
Q2 		$24.5M Buy
451,085
+4,988
+1% +$280K 0.67% 49
2015
Q1 		$24.5M Buy
446,097
+273,429
+158% +$15.5M 0.65% 53
2014
Q4 		$9.36M Buy
172,668
+139,818
+426% +$7.79M 0.25% 108
2014
Q3 		$1.86M Buy
32,850
+1,745
+6% +$98K 0.05% 221
2014
Q2 		$1.72M Sell
31,105
-759
-2% -$41.4K 0.05% 235
2014
Q1 		$1.73M Sell
31,864
-21,767
-41% -$1.13M 0.05% 231
2013
Q4 		$2.56M Sell
53,631
-115,288
-68% -$5.27M 0.08% 191
2013
Q3 		$7.67M Sell
168,919
-18,209
-10% -$831K 0.24% 115
2013
Q2 		$8.29M Buy
+187,128
New +$8.36M 0.26% 106

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Chicago Equity Partners's MRK Position: Q1 2020 in Review

Chicago Equity Partners reduced its Merck (MRK) stake by 15% in Q1 2020, selling an estimated $1.36M and leaving 101,179 shares worth $7.43M. The position accounts for 0.75% of the portfolio, ranked #14.

Chicago Equity Partners first reported a position in MRK in Q2 2013 and has held it in 28 quarters since. The position peaked at $32M in Q3 2016. 2,477 funds tracked by Wall St. Rank hold MRK as of Q1 2020.

  • Chicago Equity Partners held 101,179 shares of Merck worth $7.43M as of Q1 2020.
  • Chicago Equity Partners sold 17,282 Merck shares in Q1 2020, an estimated $1.36M.
  • Merck made up 0.75% of Chicago Equity Partners's portfolio in Q1 2020, its #14 holding.
  • Chicago Equity Partners first reported a position in Merck in Q2 2013 and has held it in 28 quarters since.
  • Chicago Equity Partners's Merck position peaked at $32M in Q3 2016.
  • 2,477 funds tracked by Wall St. Rank held Merck as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.